(Q44473140)

3 December 2017

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy (English)

1 reference

3 December 2017

1 reference

2

1 reference

3 December 2017

Talbot K

1

1 reference

3 December 2017

Crosby J

series ordinal

3

1 reference

3 December 2017

Hilton-Jones D

series ordinal

4

1 reference

3 December 2017

1 June 2003

1 reference

3 December 2017

Neuromuscular Disorders

1 reference

3 December 2017

13

1 reference

3 December 2017

5

1 reference

3 December 2017

357-364

1 reference

Myotonic dystrophy--forgotten aspects of an often neglected condition.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Apathy and hypersomnia are common features of myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Daytime somnolence in myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Daytime sleep in myotonic dystrophy is not caused by sleep apnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Selegiline in the treatment of hypersomnolence in myotonic dystrophy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Modafinil for excessive daytime sleepiness in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Daytime sleepiness and sleep habits of Australian workers.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

A normative study of the maintenance of wakefulness test (MWT).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

A behavioural test to assess daytime sleepiness in obstructive sleep apnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Short form 36 (SF36) health survey questionnaire: normative data for adults of working age

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Myotonic dystrophy with alveolar hypoventilation and hypersomnia: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Neuronal cell loss in the dorsal raphe nucleus and the superior central nucleus in myotonic dystrophy: a clinicopathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

Use of modafinil in spastic cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2803%2900030-0

7 January 2021

10.1016/S0960-8966(03)00030-0

Identifiers

DOI

1 reference

release_mb6266kzunetrgdawm65qtxn5i

3 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mb6266kzunetrgdawm65qtxn5i

24 November 2022

mapped directly with Wikidata item

1 reference